The novel coronavirus (COVID-19) pandemic is presenting the global markets with unprecedented challenges. Governments, corporations and the financial markets have been struggling to evaluate and adapt to the social and economic impact of COVID-19. We have created this three-part Client Alert to highlight some issues and considerations which, though general in nature and not intended to be exhaustive, we hope will be helpful as part of your preparations for the unique challenges ahead.

In Part 1, we discuss the key legal and practical issues that market participants should consider under the ISDA Master Agreement and related ISDA collateral agreements. In Part 2, we discuss the issues as applied to certain over-the-counter (OTC) derivatives products. In Part 3, we discuss recent derivatives regulatory issues.

COVID-19 Derivatives Checklists

This publication is provided for your convenience and does not constitute legal advice. This publication is protected by copyright.

COVID-19 Derivatives Checklists

• Download Part 1: Key ISDA Master Agreement and Collateral Agreement Issues and Considerations
• Download Part 2: Potential issues and action items on certain OTC products
• Download Part 3: Key regulatory issues and action items

[View source.]